Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138901000087119 | HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 167901000087111 | TIg HYPERTET S/D Grif | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 95961000087110 | HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | Has supplier | Grifols Canada Limited | true | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | true | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | est un(e) (attribut) | Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | a pour principe actif (attribut) | Immunoglobulin | false | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | est un(e) (attribut) | TIg tetanus immunoglobulin unspecified | false | Inferred relationship | Some | ||
| HYPERTET S/D 250 units per dose solution for injection Grifols Canada Limited (real clinical drug) | a pour principe actif (attribut) | immunoglobuline antitétanique humaine | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR